ClinicalTrials.Veeva

Menu

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

B

Biocodex

Status

Completed

Conditions

Dravet Syndrome

Treatments

Other: Retrospective study

Study type

Observational

Funder types

Industry

Identifiers

NCT05544058
STIRUS (STP228)

Details and patient eligibility

About

The present study aims to collect data regarding the history of the disease, previous and current treatments, and the clinical status of Dravet patients during the 3 months prior to stiripentol initiation, the first 3 months on stiripentol and the last 3 months on stiripentol (irrespective of stiripentol discontinuation).

Enrollment

100 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with Dravet syndrome
  • Treated with stiripentol for a minimum of 3 months in routine practice

Exclusion criteria

  • NA

Trial contacts and locations

1

Loading...

Central trial contact

Carine FRANCOIS, PharmD; Roxane NOËL, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems